- Home
- MLYS vs KNTK Comparison
MLYS vs KNTK Comparison
Compare MLYS & KNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- KNTK
- Stock Information
- Founded
- MLYS 2019
- KNTK 2017
- Country
- MLYS United States
- KNTK United States
- Employees
- MLYS N/A
- KNTK N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- KNTK Natural Gas Distribution
- Sector
- MLYS Health Care
- KNTK Utilities
- Exchange
- MLYS Nasdaq
- KNTK Nasdaq
- Market Cap
- MLYS 2.9B
- KNTK 2.4B
- IPO Year
- MLYS 2023
- KNTK N/A
- Fundamental
- Price
- MLYS $40.40
- KNTK $34.74
- Analyst Decision
- MLYS Strong Buy
- KNTK Buy
- Analyst Count
- MLYS 6
- KNTK 10
- Target Price
- MLYS $46.40
- KNTK $52.60
- AVG Volume (30 Days)
- MLYS 1.5M
- KNTK 1.3M
- Earning Date
- MLYS 11-10-2025
- KNTK 11-05-2025
- Dividend Yield
- MLYS N/A
- KNTK 9.04%
- EPS Growth
- MLYS N/A
- KNTK N/A
- EPS
- MLYS N/A
- KNTK 0.42
- Revenue
- MLYS N/A
- KNTK $1,719,686,000.00
- Revenue This Year
- MLYS N/A
- KNTK $28.80
- Revenue Next Year
- MLYS N/A
- KNTK $14.35
- P/E Ratio
- MLYS N/A
- KNTK $82.86
- Revenue Growth
- MLYS N/A
- KNTK 18.92
- 52 Week Low
- MLYS $8.24
- KNTK $32.70
- 52 Week High
- MLYS $47.65
- KNTK $67.60
- Technical
- Relative Strength Index (RSI)
- MLYS 49.69
- KNTK 42.51
- Support Level
- MLYS $36.56
- KNTK $32.70
- Resistance Level
- MLYS $47.65
- KNTK $35.74
- Average True Range (ATR)
- MLYS 3.45
- KNTK 1.54
- MACD
- MLYS -0.00
- KNTK -0.23
- Stochastic Oscillator
- MLYS 50.18
- KNTK 33.08
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About KNTK Kinetik Holdings Inc.
Kinetik Holdings Inc is a midstream operator that provides gathering and processing services to gas and oil producers as well as pipeline transportation. In addition to directly operating pipelines, Kinetik also holds ownership stakes in several pipelines. The company operates in two reportable segments which include The Midstream Logistics segment operates under three service offerings, 1) gas gathering and processing, 2) crude oil gathering, stabilization, and storage services, and 3) produced water gathering and disposal. The Pipeline Transportation segment consists of three EMI pipelines originating in the Permian Basin with various access points to the U.S. Gulf Coast, Kinetik NGL Pipelines, and Delaware Link Pipeline.